These ongoing gaps have created a need for the private sector to fill in.

The sampling tools are HSA-registered and CE-approved.

Japanese drugmakers are interested in establishing their main manufacturing sites in Thailand.

Earnings per share were 5.2% higher than that of the same period last year.

First time users will get a waiver on consultation fees, two days’ basic medication, and free delivery.

It has a three-pronged strategy for development.

The sites are ready to enroll atopic dermatitis patients into the company's multiple ascending dose study testing.

The goal is to tap into the country’s growing pharmaceutical market.